Wikidata

(Q44044782)

English

Increased oral bioavailability of topotecan in combination with the breast cancer resistance protein and P-glycoprotein inhibitor GF120918.

scientific article published in July 2002

In more languages

Statements

title
Increased oral bioavailability of topotecan in combination with the breast cancer resistance protein and P-glycoprotein inhibitor GF120918. (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
12089223
retrieved
29 November 2017
author name string
C M F Kruijtzer
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
12089223
retrieved
29 November 2017
H Rosing
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
12089223
retrieved
29 November 2017
W W ten Bokkel Huinink
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
12089223
retrieved
29 November 2017
R C Jewell
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
12089223
retrieved
29 November 2017
E M Paul
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
12089223
retrieved
29 November 2017
J H M Schellens
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
12089223
retrieved
29 November 2017
publication date
1 July 2002
1 reference
stated in
Europe PubMed Central
PubMed ID
12089223
retrieved
29 November 2017
page(s)
2943-2950
1 reference
stated in
Europe PubMed Central
PubMed ID
12089223
retrieved
29 November 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q44044782&oldid=2105920678"